UCSF

Tagged: School of Pharmacy

UCSF ranks 9th among top global universities

Using standards that measure a university's openness and diversity, as well as distinction in research, Newsweek International ranked UCSF 9th among the top 100 global universities as reported in the publication's August 13, 2006 online issue.

Communication is key to medication adherence

Patients benefit best from medications when they take the right medicines at the right dose and at the right time.

Genotyping could lead to stereotyping

While tailoring medications to a group's genetic ancestry can be important, scientists warn that these generalizations might also be misleading.

Medicare Part D coverage gap can be a black hole for some seniors

In the new United States Medicare Part D prescription drug plan, most people are responsible for 100% of their drug costs after their annual drug expenses exceed US$2,250 and until their expenses reach US$5,100.

England receives McKnight Endowment Award

Pamela M. England, PhD, UCSF School of Pharmacy faculty member and expert in the areas of neuroscience and memory formation, will receive one of four Technological Innovations in Neuroscience Awards for 2006-2008.

Inaba named first fellow of Haight Ashbury Free Clinics

Darryl Inaba, PharmD, UCSF School of Pharmacy 1971 alumnus, a substance abuse expert and former CEO of the Haight Ashbury Free Clinics, Inc., was honored on August 7, 2006 as the clinics' first fellow.

Research bias shown to be complicated

Research studies can be designed to influence the results, comments Lisa Bero, PhD, UCSF School of Pharmacy faculty member and expert on industry sponsorship of research and conflict of interest.

Part D insurers eye the bottom line

Helene Levens Lipton, PhD, UCSF School of Pharmacy faculty member and health policy expert, comments that insurers will remain in the Medicare Part D marketplace as long as they benefit.

Know your cholesterol numbers when considering a drug

Candy Tsourounis, PharmD, UCSF School of Pharmacy clinical faculty member and expert on herbals and dietary supplements, warns that depending upon your blood cholesterol levels, a cholesterol-lowering dietary supplement might not be enough for you.

Plan B under review again by the FDA

In light of the US Food and Drug Administration (FDA) July 31, 2006 announcement that it is proceeding to work toward making emergency contraception, known as Plan B, a non-prescription product for women ages 18 and older, two UCSF School of Pharmacy c

Pages